The May 26, 2020 episode of Lung Cancer Considered features a collaborative dialogue between leading patient research advocates, advocacy organizations including LCRF, and lung cancer researchers and clinicians. Topical and timely, the episode addresses the critical information that lung cancer patients need to know in the COVID-19 era, acting as a testament to the global lung cancer community’s commitment to support, solidarity and information-sharing in this difficult time.
Lung Cancer Considered is the official bi-monthly podcast of the International Association for the Study of Lung Cancer (IASLC).
Featured in this episode:
- Janet Freeman-Daily, writer, lung cancer patient, advocate and Twitter chat moderator, Lung Cancer Social Media chat (#LCSMchat)
- Jill Feldman, lung cancer advocate and patient
- Dr. Alice Berger, Assistant Professor of Human Biology, Fred Hutchinson Cancer Research Center; LCRF grantee; member of LCRF Scientific Advisory Board
- Dr. Christine Lovly, Associate Professor of Medicine, Division of Hematology and Oncology; Ingram Associate Professor of Cancer Research, Vanderbilt University Medical Center; ; member of LCRF Scientific Advisory Board
- Dr. Brendon Stiles, Associate Professor of Cardiothoracic Surgery, Weill Cornell Medical College, Cornell University; Associate Attending Cardiothoracic Surgeon, New York Presbyterian Hospital; LCRF Board Chair; LCRF Scientific Advisory Board Vice Chair
- Dr. Jan Baranski, Vice President of Scientific and Patient Programs, LCRF
- Dr. Amy Moore, Director of Science and Research, GO2 Foundation for Lung Cancer
- Dr. Upal Basu Roy, Vice President of Research, LUNGevity Foundation
Listen to the episode in the player below, or subscribe at soundcloud.com/lungcancerconsidered.